Clinical trial

Needle-free Jet Injection of Reduced-dose, Intradermal, Influenza Vaccine in >=…

NCT00386542 · Pedro Moro, U.S. Fed · Completed

Key facts

NCT number NCT00386542
Title Needle-free Jet Injection of Reduced-dose, Intradermal, Influenza Vaccine in >= 6 to < 24-month-old Children
Official title Clinical Trial of Safety (Reactogenicity) and Immunogenicity of Needle-free Jet Injection of Reduced-dose, Intradermal Influenza Vaccine (INF) Administered to >= 6 to < 24 Month-old Infants and Toddlers in the Dominican Republic
Lead sponsor Pedro Moro, U.S. Fed
Collaborators Fundación Dominicana de Infectología, Santo Domingo, Dominican Republic Hospital Infantil Dr. Robert Reid Cabral World Health Organization Pan American Health Organization PATH Bioject Medical…
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Influenza
Intervention type Biological, Device
Interventions Vaxigrip® trivalent inactivated influenza vaccine, Intradermal spacer on Biojector® 2000 jet injector
Enrollment 450
Start date Oct 1, 2006
Primary completion Nov 1, 2009
Completion May 1, 2010
First posted Oct 11, 2006
Last update posted Aug 5, 2024
Countries Dominican Republic

At a glance

  • 1–9 Study sites
  • No Results posted
  • 1–9 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies